Prolacta Bioscience News Today

Sara Pelly is a recently retired OUSD principal, and Stephen Glass is a faculty member at Cal State Long Beach.

John Nelson Pam Tanase Pam Tanase, co-founder of the coworking space Workzones in Santa Barbara; and John Nelson, chief administrative officer of Prolacta

<p><strong>Infants born extremely prematurely need to get enrichment as an addition to breast milk. But does it make any difference whether the enrichment is made from breast milk or cow’s milk when it comes to the risk of severe complications in children? This has been investigated by a large clinical study led from Linköping, Sweden, and published in <em>eClinicalMedicine.</em></strong></p>

Infants born extremely prematurely need to get enrichment as an addition to breast milk. But does it make any difference whether the enrichment is mad....

Patients undergoing allogeneic stem cell transplants could benefit from human milk-based therapy, as it may offer a healthier gut microbiome, according to research.

/PRNewswire/ -- Prolacta Bioscience, the worlds leading hospital provider of 100% human milk-based nutritional products for critically ill, premature infants,...

City of Hope researchers initiated groundbreaking Phase 2a trial using human milk-based therapy for blood cancer patients undergoing stem cell transplantation.

Bacteria found in the gut of nursing infants combined with breast milk sugars may lead to live biotherapeutics and ultimately be a game-changer for the gut health of adults.

Bacteria found in the gut of nursing infants combined with breast milk sugars may lead to live biotherapeutics and ultimately be a game-changer for the gut health of adults.

/PRNewswire/ -- Prolacta Bioscience, the worlds leading hospital provider of 100% human milk-based nutritional products for critically ill, premature infants,...